Ginkgo Bioworks Holdings, Inc. Quarterly Operating Income (Loss) in USD from Q3 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ginkgo Bioworks Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q1 2025.
  • Ginkgo Bioworks Holdings, Inc. Operating Income (Loss) for the quarter ending March 31, 2025 was -$89M, a 50% increase year-over-year.
  • Ginkgo Bioworks Holdings, Inc. Operating Income (Loss) for the twelve months ending March 31, 2025 was -$471M, a 43.1% increase year-over-year.
  • Ginkgo Bioworks Holdings, Inc. annual Operating Income (Loss) for 2024 was -$560M, a 35.2% increase from 2023.
  • Ginkgo Bioworks Holdings, Inc. annual Operating Income (Loss) for 2023 was -$864M, a 60.9% increase from 2022.
  • Ginkgo Bioworks Holdings, Inc. annual Operating Income (Loss) for 2022 was -$2.21B, a 20.8% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.